Skip to main content

Drug Binding Properties of Tyrosine-Modified Human Serum Albumin

  • Chapter
Deutsche Pharmakologische Gesellschaft
  • 21 Accesses

Abstract

Human serum albumin (HSA) has only a small number of specific binding sites for drugs. There are facts indicating that tyrosine residues may be involved in these binding sites. Thus we modified HSA with tetranitromethan, a reagent specific for tyrosine residues in proteins. As derived from an UV-absorption quotient three albumins with a degree of modification of two, five and eight residues per molecule were obtained. Only for the albumin with eight residues modified a small reduction of ordered secondary structure was found.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fehske, K.J., Wollert, U. (1978). Drug Binding Properties of Tyrosine-Modified Human Serum Albumin. In: Deutsche Pharmakologische Gesellschaft. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-39532-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-39532-5_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-38666-8

  • Online ISBN: 978-3-662-39532-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics